CAS: 2170729-29-8
AT-007
CAS:2170729-29-8
AT-007 is an orally active CNS penetrant Aldose Reductase inhibitor for the treatment of Galactosemia …
Formula:
C17H10F3N3O3S2
Purity:
99.36%
Color and Shape:
Solid
Molecular weight:
425.4
Ref: TM-T10393
| 1mg | 65.00 € | ||
| 5mg | 110.00 € | ||
| 10mg | 178.00 € | ||
| 25mg | 325.00 € | ||
| 50mg | 527.00 € | ||
| 100mg | 734.00 € | ||
| 1mL*10mM (DMSO) | 123.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
![2-(4-Oxo-3-((5-(trifluoromethyl)benzo[d]thiazol-2-yl)methyl)-3,4-dihydrothieno[3,4-d]pyridazin-1-y…](https://static.cymitquimica.com/products/IN/thumb/DA01V487.jpg)
2-(4-Oxo-3-((5-(trifluoromethyl)benzo[d]thiazol-2-yl)methyl)-3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid
CAS:2170729-29-8
Formula:
C17H10F3N3O3S2
Purity:
98%
Molecular weight:
425.4048
Ref: IN-DA01V487
| 1mg | 67.00 € | ||
| 5mg | 127.00 € | ||
| 10mg | 166.00 € | ||
| 50mg | 319.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
![2-(4-Oxo-3-((5-(trifluoromethyl)benzo[d]thiazol-2-yl)methyl)-3,4-dihydrothieno[3,4-d]pyridazin-1-y…](https://static.cymitquimica.com/products/10/thumb/F546907.jpg)
2-(4-Oxo-3-((5-(trifluoromethyl)benzo[d]thiazol-2-yl)methyl)-3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid
CAS:2170729-29-8
Purity:
98.0%
Molecular weight:
425.3999938964844
Ref: 10-F546907
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
AT-007
CAS:2170729-29-8
AT-007 is a research tool to be used as an activator, ligand, or receptor. It …
Formula:
C17H10F3N3O3S2
Purity:
Min. 95%
Molecular weight:
425.4 g/mol
Ref: 3D-VLD72929
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025
